Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic

Beyond the FDA PRO Guidance: Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels

(2012) Ethan Basch   VALUE IN HEALTH

Physical and psychosocial impact of acne in adult females

(2012) GavneetK Pruthi et al.   INDIAN JOURNAL OF DERMATOLOGY

Dermatologic manifestations of cytotoxic therapy

(2011) VICTOR HUANG et al.   Dermatologic Therapy

The risk of nail changes with epidermal growth factor receptor inhibitors: A systematic review of the literature and meta-analysis

(2011) Benjamin C. Garden et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Commentary: Encouraging Clinicians to Incorporate Longitudinal Patient-Reported Symptoms in Routine Clinical Practice

(2011) Ethan Basch et al.   Journal of Oncology Practice

Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life

(2010) Smita S. Joshi et al.   CANCER

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial

(2010) Galina Velikova et al.   EUROPEAN JOURNAL OF CANCER

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

(2010) Mario E. Lacouture et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Sedative and Non-Sedative Antihistamines on the Impaired Productivity and Quality of Life in Patients with Pruritic Skin Diseases

(2010) Hiroyuki Murota et al.   ALLERGOLOGY INTERNATIONAL

Search for Evidence-Based Approaches for the Prevention and Palliation of Hand-Foot Skin Reaction (HFSR) Caused by the Multikinase Inhibitors (MKIs)

(2009) R. Anderson et al.   ONCOLOGIST

Unanticipated toxicities from anticancer therapies: Survivors’ perspectives

(2009) Mona Gandhi et al.   SUPPORTIVE CARE IN CANCER

Skin toxicities associated with epidermal growth factor receptor inhibitors

(2009) Tianhong Li et al.   Targeted Oncology

Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of experts

(2008) Roger von Moos et al.   EUROPEAN JOURNAL OF CANCER

Evolving Strategies for the Management of Hand-Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib

(2008) M. E. Lacouture et al.   ONCOLOGIST